New RNA Therapies for Treatment of ASCVD, Prevention, and Dyslipidemia

New RNA Therapies for Treatment of ASCVD, Prevention, and Dyslipidemia   Guest: R. Scott Wright, M.D. Host: Stephen L. Kopecky, M.D.   RNA therapies are growing in number as targeted treatments for dyslipidemia including LDL-c, Lp(a) and Triglycerides. The podcast will explore the science behind these therapies, the evidence for safety and how clinicians can utilize them in their practices.    Topics Discussed: What are the new RNA therapies available or soon to be available? How are RNA based therapies being used? How do they compare to the COVID-19 vaccine? What is their effectiveness and side effect profile? Are there side effects or concerns?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here.